# bivalirudin

NDC: 70436-025
Generic name: bivalirudin
Labeler / Manufacturer: Slate Run Pharmaceuticals, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Routes: INTRAVENOUS
Marketing started: 20210630

FDA application: ANDA213078

## Active ingredients

- BIVALIRUDIN: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70436-025"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70436-025
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5d9a45c6-e234-4d56-9132-5e24e65852e6